Spirometry Market

Growing diagnostic tool technological progress and increasing COPD prevalence to boost the market growth

To assess the fundamental operation of the lungs, lung function tests are important. Physicians can diagnose various lung illnesses, including COPD, by evaluating PFTs, which measure lung volumes, lung capacities, rates of flow, and gas exchange. On the market, technological advancements are anticipated to have a significant impact. Early diagnosis of COPD is anticipated to be made possible by significant expenditures made by the major market participants in the substantial research and development of novel and cutting-edge diagnostic and monitoring technologies.

The underutilization of pulmonary function testing has been addressed by creating portable, hand-held, and user-friendly spirometry devices. For instance, the U.S. FDA approved NuvoAir's linked spirometer for nationwide sales in January 2020. The system treats conditions like cystic fibrosis, asthma, and COPD. Thus, one of the market-driving growth elements is ongoing innovation.

The third biggest cause of death globally, COPD places a heavy burden on patients and healthcare systems. According to the National Heart, Lung, and Blood Institute, COPD, which affects about 16 million Americans, is the main cause of death in the country. Smoking is a significant risk factor for COPD. Yet, other environmental exposures like exposure to biomass fuels and air pollution may also harm your health.

The Global Spirometry Market Industry is poised for substantial growth, with projections indicating a market value of 0.73 USD Billion in 2024 and an anticipated increase to 1.73 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 8.2% from 2025 to 2035. Such projections underscore the increasing demand for spirometry devices driven by various factors, including the rising prevalence of respiratory diseases, technological advancements, and government initiatives. The market's expansion is indicative of a broader recognition of the importance of respiratory health and the role of spirometry in effective diagnosis and management.

The expanding geriatric population worldwide is a significant factor influencing the Global Spirometry Market Industry. Older adults are more susceptible to respiratory diseases due to age-related physiological changes and comorbidities. This demographic shift necessitates regular respiratory assessments, thereby increasing the demand for spirometry devices. According to demographic studies, the proportion of individuals aged 65 and older is expected to rise substantially in the coming years. This trend underscores the importance of spirometry in managing respiratory health in older populations, suggesting a robust market growth trajectory with a projected CAGR of 8.2% from 2025 to 2035.

The heightened awareness and education regarding respiratory health are pivotal in driving the Global Spirometry Market Industry. Healthcare professionals and patients are increasingly recognizing the importance of early detection and management of respiratory conditions. Educational programs and resources provided by health organizations are instrumental in promoting the use of spirometry as a diagnostic tool. This growing awareness is likely to lead to higher adoption rates of spirometry devices across various healthcare settings. Consequently, the market is expected to experience sustained growth, supported by informed patients and proactive healthcare providers.

Government initiatives aimed at improving respiratory health are crucial drivers for the Global Spirometry Market Industry. Many countries are implementing policies to enhance early diagnosis and management of respiratory diseases. For example, public health campaigns and funding for research into respiratory conditions are becoming more prevalent. These initiatives not only raise awareness but also encourage healthcare systems to adopt spirometry as a standard diagnostic tool. As a result, the market is likely to benefit from increased investments and support, fostering an environment conducive to growth and innovation in spirometry technology.

The increasing incidence of respiratory diseases globally is a primary driver for the Global Spirometry Market Industry. Conditions such as asthma, chronic obstructive pulmonary disease, and other pulmonary disorders are on the rise, necessitating effective diagnostic tools. For instance, the World Health Organization indicates that respiratory diseases account for a significant portion of global morbidity and mortality. This trend is expected to propel the market, with projections suggesting that the market will reach 0.73 USD Billion in 2024. As awareness of respiratory health grows, the demand for spirometry devices is likely to expand, further contributing to market growth.

Technological innovations in spirometry devices are reshaping the Global Spirometry Market Industry. Modern spirometers are increasingly equipped with advanced features such as wireless connectivity, real-time data analysis, and integration with electronic health records. These enhancements improve the accuracy and efficiency of respiratory assessments, making them more appealing to healthcare providers. The introduction of portable and user-friendly devices also facilitates home monitoring, which is gaining traction among patients. As a result, the market is anticipated to grow significantly, with a projected value of 1.73 USD Billion by 2035, reflecting the impact of these technological advancements.

By Region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World. The fact that North America held the largest market share in 2022 (41.8%) was mostly caused by the rising incidence of respiratory disorders. Spirometers, which aid in disease control and are frequently used by doctors in hospitals, have become more popular due to the rise in occurrences of asthma and COPD. The United States has also been noted as an early adopter of technologies that helps lower COPD rates. Due to those above, the market is anticipated to expand throughout the forecast period.

Further, the major countries studied in the market report are The U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: SPIROMETRY MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe's spirometry market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an aging population, and an increase in the incidence of COPD and asthma disorders. Further, the German spirometry market held the largest market share, and the U.K. spirometry market was the fastest-growing market in the European Region.

The Asia-Pacific Spirometry Market is expected to grow at the fastest CAGR from 2023 to 2030. The Asia Pacific market is anticipated to be driven by improvements in primary care activities for the early detection and management of chronic lung illnesses, including COPD and asthma, over the forecasted period. Moreover, China's spirometry market held the largest market share, and the Indian spirometry market was the fastest-growing market in the Asia-Pacific region.

Leading industry players are investing a lot of money in R&D to expand their product offerings, which will spur further market growth for spirometry. With significant industry changes like new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market participants are also undertaking various strategic activities to expand their global presence. Spirometry sector competitors must provide affordable products to grow and survive in a more cutthroat and competitive market climate.

Manufacturing locally to cut operating costs is one of the main business tactics manufacturers use in the global spirometry industry to benefit customers and develop the market sector. The spirometry market major player such as NDD Medical Technologies Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), and others are working on expanding the market demand by investing in research and development activities.

Schiller AG (Switzerland) is a top producer and supplier of software solutions for the medical sector and devices for cardiopulmonary diagnostics, defibrillation, and patient monitoring. Schiller has dedicated more than 40 years to the struggle against sudden cardiac death. In 2018, Schiller AG opened a new manufacturing site in Guangzhou, China.

Also, Tactio Health Group (Canada) is a world leader in mobile health systems, with millions using its mobile health applications on iOS and Android, enjoying the personal and family benefits of being led to live a more active, healthier lifestyle. In 2017, MIR partnered with Tactio Health Group to develop telemedicine solutions for COPD.